miR-126对细胞周期的调控及其与肺癌患者预后的关系 |
| |
引用本文: | 李勋光,;万珙善,;梁艳霞,;苏长青,;董洪芳.miR-126对细胞周期的调控及其与肺癌患者预后的关系[J].实用肿瘤杂志,2014(5):440-445. |
| |
作者姓名: | 李勋光 ;万珙善 ;梁艳霞 ;苏长青 ;董洪芳 |
| |
作者单位: | [1]赣榆县人民医院呼吸科,江苏赣榆222100; [2]上海第二军医大学东方肝胆医院检验科,上海201802 |
| |
基金项目: | 2012年连云港市卫生局指令性课题1241号 |
| |
摘 要: | 目的研究miR-126在肺癌中的表达变化及其与癌细胞周期调控的关系,并分析miR-126表达对肺癌患者术后生存期的影响。方法对肺癌细胞株A549和49例临床肺癌手术标本进行实时定量RT-PCR检测miR-126的表达;A549细胞转染miR-126表达载体,MTT和流式细胞术检测miR-126表达对癌细胞增殖和细胞周期的影响;Kaplan-Meier曲线和log-rank分析方法比较miR-126高、低表达组之间无瘤生存期和总生存期的差别。结果A549肺癌细胞miR-126低表达(2.10±0.67),转染miR-126表达载体后,miR-126表达升高(12.33±1.67);转染miR-126后96小时,A549细胞存活率为(68.33±6.67)%,明显低于亲本A549细胞(105.33±8.58)%,差异有统计学意义(P〈0.001);与亲本A549细胞比较(G0/G1期:37.48±3.28;S期:62.03±5.23),转染miR-126的A549细胞G0/G1期细胞比例上升(53.67±6.06),S期下降(43.21±3.75),差异有统计学意义(P〈0.001);肺癌组织miR-126表达水平(12.41±4.34)明显低于癌旁肺组织(23.29±6.28),差异有统计学意义(P〈0.001);miR-126高表达组无瘤生存期和总生存期均明显高于低表达组(P〈0.01,P〈0.001)。结论 miR-126在肺癌的发生、发展中有重要作用,可能成为肺癌治疗的可选靶点之一。
|
关 键 词: | 肺肿瘤/病理学 微RNAs 转染 细胞增殖 细胞周期 存活率 预后 聚合酶链反应 |
Effect of miR-126 on cell cycle regulation and prognosis of lung cancer patients |
| |
Institution: | LI Xun-guang, WAN Gong-shan, LIANG Yan-xia, et al ( Department of Respiration, Ganyu County People's Hospital, Ganyu, 222100, China) |
| |
Abstract: | Objective To investigate the expression of miR-126 in lung cancer and the relationship with cancer cell cycle regulation and to analyze the effect of miR-126 expression on postoperative survival of patients with lung cancer.Methods miR-126 expression was detected in lung carcinoma cell line A549 and lung cancer tissues from 49 cases by real-time quantitative RT-PCR; A549 cells were transfected with miR-126 expression vector and cell viability and cell cycle were determined by MTT and flow cytometry,respectively; Kaplan Meier curves and log-rank analysis were used to compare the differences in disease-free survival( DFS) and overall survival( OS) between high and low miR-126 expression groups.Results The expression of miR-126 was lower in A549 cells( 2. 10 ± 0. 67) and after transfection of miR-126 expression vector,the expression level of miR-126 was increased( 12. 33 ± 1. 67); The cell viability of A549 cells 96 h after transfection of miR-126 was( 68. 33 ± 6. 67) %,significantly lower than that of parental A549 cells( 105. 33 ± 8. 58) %( P〈 0. 001); Compared with parental A549 cells( G0/G1phase: 37. 48 ± 3. 28; S phase: 62. 03 ± 5. 23),miR-126-transfected A549 cells showed an increase in G0/G1phase( 53. 67 ± 6. 06) and a decrease in S phase( 43. 21 ± 3. 75),P 〈0. 001; miR-126 expression level was significantly lower in lung cancer tissues( 12. 41 ± 4. 34) than that in lung tissues adjacent to cancer( 23. 29 ± 6. 28),P〈 0. 001; DFS and OS were significantly higher in the group with high miR-126 level than those in the low level group( P〈 0. 01,P 〈0. 001). Conclusion miR-126 plays an important role in the oncogenesis and development of lung cancer and may be an optional target for lung cancer therapy. |
| |
Keywords: | lung neoplasms/pathology microRNAs transfection cell proliferation cell cycle survival rate prognosis polymerase chain reaction |
本文献已被 维普 等数据库收录! |
|